TERUMO CORPORATION Funds and ETFs Terumo Corporation
Equities
4543
JP3546800008
Medical Equipment, Supplies & Distribution
|
Delayed
Other stock markets
|
5-day change | 1st Jan Change | ||
| 2,724 JPY | -2.56% |
|
+3.67% | +17.85% |
| 05-15 | Correction: Terumo’s Profit Up 47% in Fiscal 2024 | MT |
| 05-15 | Terumo’s Profit Up 47% in Fiscal 2023 | MT |
ETFs positioned on Terumo Corporation
| Name | Weight | AuM | 1st Jan change | Investor Rating |
|---|---|---|---|---|
| 0.01% | 8 M€ | +1.26% | - | |
| 0.01% | 54 M€ | +1.52% | - | |
| 0.01% | 234 M€ | +6.34% | - |
Terumo Corporation specializes in the design, manufacturing and marketing of medical products and equipments. Net sales break down by family of products as follows:
- cardiac surgery devices (53.5%);
- medical products for hospitals (28.6%): medical devices, nutritional additives, oxygen, medical measuring devices (thermometers, tensiometers, glucometers, etc.), etc.;
- sanguine transfusion equipments (17.9%).
Net sales break down geographically as follows: Japan (32.9%), America (29.5%), Europe (19.6%), China (7.4%) and other (10.6%).
Calendar
2024-08-06
- Q1 2024 Earnings Release (Projected)
Trading Rating
Investor Rating
ESG Refinitiv
A-
Sell
Buy
Mean consensus
BUY
Number of Analysts
13
Last Close Price
2,795
JPY
Average target price
2,976
JPY
Spread / Average Target
+6.47%
EPS Revisions
| 1st Jan change | Capi. | |
|---|---|---|
| +17.85% | 26.73B | |
| -4.72% | 182B | |
| +3.96% | 114B | |
| -2.93% | 68.38B | |
| +6.30% | 52.46B | |
| +8.02% | 44.25B | |
| +7.52% | 43.55B | |
| +26.18% | 32.69B | |
| +0.57% | 25.79B | |
| -0.38% | 24.94B |
- Stock Market
- Equities
- 4543 Stock
- Funds and ETFs Terumo Corporation
